GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma

Glioma-associated oncogene (Gli) antagonist-61 (GANT61) not only suppresses the malignant behavior of several cancers but also presents synergistic effects with other anticancer agents on suppressing the progression of cancers, while relevant information is rare in anaplastic thyroid carcinoma (ATC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Haoji, Wang, Weige, Li, Qinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067515/
https://www.ncbi.nlm.nih.gov/pubmed/35491899
http://dx.doi.org/10.1080/15384047.2022.2051158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067515/
https://www.ncbi.nlm.nih.gov/pubmed/35491899
http://dx.doi.org/10.1080/15384047.2022.2051158

Ejemplares similares